This man is not fit to represent our Company. Honestly, I think the Company is riding out a particularly difficult period due to the awful acquisition of Guident. But to hear him speak is a disgrace. It's going to come back and bite the Company. He should be removed from the BOD.
It wouldn't be such a bad idea. We have all seen what a lack of access to capital could do. Take advantage of the recent stock move to firm up their capital position. The downward move would only be temporary. If it happens it would be after earnings are reported.
I called but have received no response. I had 7k shares now down to 5k as of yesterday. No new news or update from the company can not be good. I have copied the pertinent paragraph of their Oct 17th press release below:
WARRINGTON, Pa., Oct. 17, 2008 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) today submitted its Complete Response to the May 2008 Approvable Letter issued by the U.S. Food and Drug Administration (FDA) for Surfaxin(r) (lucinactant) for the prevention of Respiratory Distress Syndrome (RDS) in premature infants. The FDA's guidelines provide that by October 31, the FDA will determine the classification of the submission and notify Discovery Labs of its target date for potential approval of Surfaxin. Discovery Labs believes that the FDA may designate the Complete Response as a Class 1 resubmission, which would result in a target review period of sixty-days and potential approval of Surfaxin in 2008.